跳至主要内容
临床试验/JPRN-UMIN000020864
JPRN-UMIN000020864已完成2 期

Randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer.(WJOG8315G) - Randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer.(WJOG8315G)

West Japan Oncology Group0 个研究点目标入组 160 人开始时间: 2016年2月3日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
70years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal carcinoma. 2) Active infection under treatment 3) Peripheral sensory neuropathy of grade >= 2 according to NCI-CTCAE version 4.0. 4) Diarrhea of grade >= 2 according to NCI-CTCAE version 4.0. 5) Pulmonary fibrosis or interstitial pneumonitis detected by chest x-ray. 6) Receiving flucytosine 7) Receiving phenytoin or warfarin potassium 8) Current treatment with corticosteroids. 9) Pregnant or lactating female. 10) Uncontrolled psychiatry disease 11) History of serious allergic reactions. 12) Evidence of any other serious disease, e.g. COPD, uncontrolled diabetes mellitus, uncontrolled hypertension, uncontrolled cardiovascular disease, Cerebral infarction within one year, active gastrointestinal hemorrhage, blood tests positive for HBs antigen or HVC antibody. 13) Judged inappropriate by the investigators.

研究者

相似试验